Erratum to: Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients

被引：0
|
作者：
Takuya Wakamiya
Tatsunori Hokosaki
Shin-ichi Tsujimoto
Keisuke Kadota
Yusuke Nakano
Shigeo Watanabe
Mari Iwamoto
Masakatsu Yanagimachi
Shuichi Ito
机构：
[1] Yokohama City University School of Medicine,Department of Pediatrics
来源：
Molecular Diagnosis & Therapy | 2016年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 501
相关论文
共 50 条
  • [1] Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients (vol 20, pg 393, 2016)
    Wakamiya, Takuya
    Hokosaki, Tatsunori
    Tsujimoto, Shin-ichi
    Kadota, Keisuke
    Nakano, Yusuke
    Watanabe, Shigeo
    Iwamoto, Mari
    Yanagimachi, Masakatsu
    Ito, Shuichi
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (05) : 501 - 501
  • [2] Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population
    Vear, Susan I.
    Ayers, Gregory D.
    Stein, C. Michael
    Ho, Richard H.
    [J]. BLOOD, 2012, 120 (21)
  • [3] Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients
    Wakamiya, Takuya
    Hokosaki, Tatsunori
    Tsujimoto, Shin-ichi
    Kadota, Keisuke
    Nakano, Yusuke
    Watanabe, Shigeo
    Iwamoto, Mari
    Yanagimachi, Masakatsu
    Ito, Shuichi
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (04) : 393 - 400
  • [4] Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients
    Takuya Wakamiya
    Tatsunori Hokosaki
    Shin-ichi Tsujimoto
    Keisuke Kadota
    Yusuke Nakano
    Shigeo Watanabe
    Mari Iwamoto
    Masakatsu Yanagimachi
    Shuichi Ito
    [J]. Molecular Diagnosis & Therapy, 2016, 20 : 393 - 400
  • [5] The effect of polymorphisms in CYP2C9, CYP4F2, EPHX1 and VKORC1 on warfarin dose in Turkish patients
    Ozer, Mahmut
    Demirci, Yeliz
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Hizel, Candan
    Alpan, Serdar
    Genc, Ece
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S125 - S125
  • [6] Study of VKORC1, CYP2C9, and CYP4F2 polymorphisms and their association with warfarin dose requirements in Egyptian patients.
    Shahin, Mohamed H.
    Khalifa, Sherief I.
    Sallam, Tarif H.
    Hammad, Lamiaa N.
    El Shafey, Mostafa
    Ali, Shawky S.
    Mohamed, Mohamed-Eslam F.
    Langaee, Taimour
    Johnson, Julie A.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1065 - 1065
  • [7] Impact of VKORC1, CYP2C9, and CYP4F2 Polymorphisms on Optimal Warfarin Dose: Does Ethnicity Matters?
    Li, Jia X.
    Kim, Moo H.
    Song, Kai
    Guo, Long Z.
    Jin, En Z.
    Kim, Soo J.
    Lee, Kwang M.
    Serebruany, Victor
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E461 - E468
  • [8] Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU
    Scott, Stuart A.
    Patel, Manishkumar
    Martis, Suparna
    Lubitz, Steven A.
    van der Zee, Sarina
    Yoo, Chang
    Edelmann, Lisa
    Halperin, Jonathan L.
    Desnick, Robert J.
    [J]. PHARMACOGENOMICS, 2012, 13 (03) : 297 - 307
  • [9] CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis
    Takeuchi, Masanobu
    Kobayashi, Tohru
    Biss, Tina
    Kamali, Farhad
    Vear, Susan I.
    Ho, Richard H.
    Bajolle, Fanny
    Loriot, Marie-Anne
    Shaw, Kaitlyn
    Carleton, Bruce C.
    Hamberg, Anna-Karin
    Wadelius, Mia
    Hirono, Keiichi
    Taguchi, Masato
    Wakamiya, Takuya
    Yanagimachi, Masakatsu
    Hirai, Keita
    Itoh, Kunihiko
    Brandao, Leonardo R.
    Ito, Shinya
    [J]. PHARMACOGENOMICS JOURNAL, 2020, 20 (02): : 306 - 319
  • [10] CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis
    Masanobu Takeuchi
    Tohru Kobayashi
    Tina Biss
    Farhad Kamali
    Susan I. Vear
    Richard H. Ho
    Fanny Bajolle
    Marie-Anne Loriot
    Kaitlyn Shaw
    Bruce C. Carleton
    Anna-Karin Hamberg
    Mia Wadelius
    Keiichi Hirono
    Masato Taguchi
    Takuya Wakamiya
    Masakatsu Yanagimachi
    Keita Hirai
    Kunihiko Itoh
    Leonardo R. Brandão
    Shinya Ito
    [J]. The Pharmacogenomics Journal, 2020, 20 : 306 - 319
12345